Updating!
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by TRANSGENE SA
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
15F-15D | Document | Notice of a foreign private issuer’s suspension of duty to file reports pursuant to Section 13 and 15(d) of the Act Acc-no: 0001104659-12-001475 (34 Act) Size: KB |
Jan-11-2012 | 12521271 |
15-15D | Document | Notice of suspension of duty to file reports pursuant to Section 13 and 15(d) of the Act Acc-no: 0001047469-06-004456 (34 Act) Size: KB |
Apr-03-2006 | 06732958 |
15-12G | Document | Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0001047469-06-004452 (34 Act) Size: KB |
Apr-03-2006 | 06732797 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001309014-06-000112 (34 Act) Size: KB |
Feb-22-2006 | 06634730 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001309014-06-000043 (34 Act) Size: KB |
Jan-25-2006 | 06547934 |
UPLOAD | Document | Acc-no: 0000000000-06-002548 ( Act) Size: KB | Jan-17-2006 | |
20-F/A | Document | Amendment to Annual and transition report of foreign private issuers pursuant to sections 13 or 15(d) Acc-no: 0001047469-05-028457 (34 Act) Size: KB |
Dec-20-2005 | 051274193 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001309014-05-000796 (34 Act) Size: KB |
Dec-12-2005 | 051257005 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001309014-05-000774 (34 Act) Size: KB |
Nov-30-2005 | 051233296 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001309014-05-000740 (34 Act) Size: KB |
Nov-17-2005 | 051211387 |
CORRESP | Document | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0000950123-05-013019 ( Act) Size: KB |
Nov-03-2005 | |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001309014-05-000685 (34 Act) Size: KB |
Oct-24-2005 | 051150859 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001309014-05-000653 (34 Act) Size: KB |
Oct-13-2005 | 051136274 |
F-6 POS | Document | Post-effective amendment to a F-6EF registration Acc-no: 0001019155-05-000235 (33 Act) Size: KB |
Oct-12-2005 | 051134984 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001309014-05-000590 (34 Act) Size: KB |
Sep-21-2005 | 051094937 |
CORRESP | Document | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0000950123-05-010740 ( Act) Size: KB |
Sep-06-2005 | |
UPLOAD | Document | Acc-no: 0000000000-05-044193 ( Act) Size: KB | Aug-25-2005 | |
SC 13D/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000898080-05-000368 (34 Act) Size: KB |
Aug-09-2005 | 051009852 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001309014-05-000455 (34 Act) Size: KB |
Aug-03-2005 | 05993826 |
SC 13D/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000898080-05-000351 (34 Act) Size: KB |
Jul-28-2005 | 05982096 |
Recent 20 filings. View all TRANSGENE SA filings
Very good communication and delivery made within the timeframe I was advised of
Thanks I look forward to using the product to improve my skin tone
Huge help thank you for your help .. y'all make it so much easier
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by